Compare Stocks → The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison OTCMKTS:GPRCOTCMKTS:KSHBNASDAQ:YTEN Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGPRCBiochar Now$0.00$0.00▼$0.00N/AN/AN/AN/AKSHBKushCo$0.70+0.1%$0.70$0.43▼$2.10N/AN/AN/A538,000 shsYTENYield10 Bioscience$0.27-3.5%$0.29$0.18▼$3.29$4.29M1.588.40 million shs276,391 shs10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGPRCBiochar Now0.00%0.00%0.00%0.00%0.00%KSHBKushCo0.00%0.00%0.00%0.00%0.00%YTENYield10 Bioscience-2.08%-14.78%+13.15%+32.38%-91.09%Biden’s $374B Giveaway Into This Sector (Ad)Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full storyMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGPRCBiochar NowN/AN/AN/AN/AN/AN/AN/AN/AKSHBKushCoN/AN/AN/AN/AN/AN/AN/AN/AYTENYield10 Bioscience0.5542 of 5 stars3.22.00.00.01.10.00.0Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGPRCBiochar NowN/AN/AN/AN/AKSHBKushCoN/AN/AN/AN/AYTENYield10 Bioscience2.33Hold$3.501,183.46% UpsideCurrent Analyst RatingsLatest GPRC, YTEN, and KSHB Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails2/8/2024YTENYield10 BioscienceLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGPRCBiochar NowN/AN/AN/AN/AN/AN/AKSHBKushCoN/AN/AN/AN/AN/AN/AYTENYield10 Bioscience$60K70.00N/AN/A($0.21) per share-1.30Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGPRCBiochar NowN/AN/A0.00N/AN/AN/AN/AN/AN/AKSHBKushCoN/AN/A0.00∞N/AN/AN/AN/AN/AYTENYield10 Bioscience-$14.45M-$2.08N/A∞N/AN/A-888.81%-273.34%5/8/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGPRCBiochar NowN/AN/AN/AN/AN/AKSHBKushCoN/AN/AN/AN/AN/AYTENYield10 BioscienceN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGPRCBiochar NowN/AN/AN/AKSHBKushCoN/AN/AN/AYTENYield10 BioscienceN/A0.290.29OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGPRCBiochar NowN/AKSHBKushCoN/AYTENYield10 Bioscience4.91%Insider OwnershipCompanyInsider OwnershipGPRCBiochar Now61.57%KSHBKushCo17.30%YTENYield10 Bioscience6.10%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableGPRCBiochar Now540N/AN/ANot OptionableKSHBKushCo109N/AN/ANot OptionableYTENYield10 Bioscience3015.40 million14.46 millionNot OptionableGPRC, YTEN, and KSHB HeadlinesSourceHeadlineYield10 Bioscience (NASDAQ:YTEN) Stock Price Passes Above 200 Day Moving Average of $0.27americanbankingnews.com - April 19 at 3:20 AMYield10 Bioscience (NASDAQ:YTEN) Shares Cross Above 200-Day Moving Average of $0.27americanbankingnews.com - April 11 at 2:36 AMShort Interest in Yield10 Bioscience, Inc. (NASDAQ:YTEN) Expands By 292.2%americanbankingnews.com - April 11 at 1:22 AMYield10 Bioscience, Inc. (NASDAQ:YTEN) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - April 5 at 12:37 PMHold Recommendation on Yield10 Bioscience Amid Commercialization and Capital Uncertaintiesmarkets.businessinsider.com - April 3 at 6:59 PMQ4 2023 Yield10 Bioscience Inc Earnings Callfinance.yahoo.com - April 2 at 7:55 AMYTEN Stock Earnings: Yield10 Bioscience Beats EPS for Q4 2023investorplace.com - April 1 at 9:06 PMYield10 Bioscience: Q4 Earnings Insightsbenzinga.com - April 1 at 4:54 PMYield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - April 1 at 4:01 PMYield10 Bioscience gets grant for genetically engineered oilseed plant expressing plant proteinpharmaceutical-technology.com - March 29 at 9:58 AMYield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024globenewswire.com - March 28 at 4:01 PMYield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canadaglobenewswire.com - March 26 at 8:29 AMUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesstockhouse.com - March 23 at 5:41 PMDow Jumps 200 Points; US Weekly Jobless Claims Fallmarkets.businessinsider.com - March 21 at 3:32 PMUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesmarkets.businessinsider.com - March 21 at 3:32 PMYield10 stock soars 120% on USDA okay for Camelina plantingmsn.com - March 21 at 3:32 PMUSDA-APHIS Determines that Yield10 Bioscience’s Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesfinance.yahoo.com - March 21 at 3:32 PMWhy Is Yield10 (YTEN) Stock Up 117% Today?investorplace.com - March 21 at 11:05 AMUSDA-APHIS Determines that Yield10 Bioscience's Omega-3 Camelina Varieties May Be Planted and Bred in the United Statesglobenewswire.com - March 21 at 8:29 AMYield10 Bioscience Inc.barrons.com - March 10 at 7:10 AMYield10 Bioscience Reports that Proprietary Varieties of Winter Camelina Show Tolerance to Commonly Used Herbicides in First Field Testsglobenewswire.com - February 29 at 8:31 AMYield10 Bioscience: Other Events, Financial Statements And Exhibitscbonds.com - February 16 at 10:00 AMYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstockfinance.yahoo.com - February 14 at 1:02 PMYield10 Bioscience Grants Global License to VISION Bioenergy Oilseeds for Herbicide Tolerant Camelina Cultivated for the Production of Biofuel Feedstockglobenewswire.com - February 14 at 9:00 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBiochar NowOTCMKTS:GPRCGuanwei Recycling Corp. manufactures and distributes low density polyethylene (LDPE) and other recycled plastics products primarily in the People's Republic of China and internationally. It imports and recycles LDPE plastic scrap material into granular plastic for use in the manufacture of various consumer products. The company's LDPE products are used in the manufacture of chemical and functional fibers, as well as a raw material in the manufacture of shoe soles, insulation materials, fire-proofing and water-proofing materials, and foam. It also sells its products to customers in a range of industries, including shoe manufacturing, architecture and engineering products, industrial equipment and supplies, and chemical and petrochemical manufacturing. Guanwei Recycling Corp. was founded in 2005 and is based in Fuqing, the People's Republic of China.KushCoOTCMKTS:KSHBKushCo Holdings, Inc. provides ancillary products and services to the legal cannabis and CBD industries. The firm through its subsidiaries and brands provides product quality, exceptional customer service, compliance knowledge and a local presence in serving diverse customer base. The company was founded by Dallas Imbimbo, John Kovacevich, Nicholas Kovacevich, and Jeffrey Meng on December 15, 2010 and is headquartered in Cypress, CA.Yield10 BioscienceNASDAQ:YTENYield10 Bioscience, Inc. operates as agricultural bioscience company in the United States. The company primarily focus on production of low carbon products through processing Camelina seeds. Its products include Camelina oil for low carbon biofuel feedstock; Omega-3 oils for nutrition; and PHA bioplastics for biodegradable zero waste packaging solutions. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporated in 1992 and is headquartered in Woburn, Massachusetts. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.